Esso 40mg 1Vial Inj is primarily indicated in conditions like Gastric ulcer, Gastro-esophageal reflux disease, NSAID-associated ulceration, Zollinger-ellison syndrome, and can also be given in adjunctive therapy as an alternative drug of choice in Pernicious anaemia and other macrocytic anaemias.
Esso 40mg 1Vial Inj is contraindicated in conditions like Hypersensitivity to the drug.
The severe or irreversible adverse effects of Esso 40mg 1Vial Inj , which give rise to further complications include Liver damage. The symptomatic adverse reactions produced by Esso 40mg 1Vial Inj are more or less tolerable and if they become severe, they can be treated symptomatically, these include Flatulence, Dizziness, Headache, Fatigue, Diarrhea, Myalgia, Constipation, Abdominal pain, Dry mouth, Blurred vision, Rashes, Pruritus, Malaise, Arthralgia, Nausea and vomiting, Musculoskeletal pain, Dry mouth, dizziness, subacute myopathy, athralgia.
Esso 40mg 1Vial Inj should be given with caution in patients with renal impairment, liver disease, in pregnancy and in breast-feeding. Proton-pump inhibitors may mask symptoms of gastric cancer, particular care is required in those whose symptoms change and in those over 45 years of age; the presence of gastric malignancy should be excluded before treatment.